Exome Sequencing Enhances Screening for Familial Hypercholesterolemia Within a Multi-Site Healthcare System
Circulation: Genomic and Precision Medicine · 2025
DOI: 10.1161/circgen.125.005174 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Genomic and Precision Medicine, 2025. Verfasst von N Jewel Samadder und 28 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology & Hepatology, Department of Medicine (N.J.S.), Mayo Clinic, Phoenix, AZ. Genetic Counseling program, Arizona State Unive…. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Exome Sequencing, Genetic Testing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder that increases risk for premature coronary artery disease and has accessible and effective interventions. The Dutch lipid clinic network is currently the most used diagnostic criterion; however, genetic sequencing provides a definitive diagnosis of FH. The goals of this study were to determine whether germline genetic screening using exome sequencing could be used to efficiently identify individuals who were genotype positive for FH. METHODS: Participants were recruited from 3 geographically and racially diverse sites in the United States (Rochester, MN; Phoenix, AZ; and Jacksonville, FL). Participants underwent Exome+ sequencing (dba Helix, San Mateo, CA) and return of results for specific genetic findings in APOB , LDLR , or PCSK9 . A chart review was performed to collect demographics, personal, and family cardiovascular history. RESULTS: At the time of the study, 84 413 participants were enrolled in the Tapestry study. Annotation and interpretation of all variants in genes for FH resulted in the identification of 419 likely pathogenic and pathogenic variants (prevalence, 0.50%), which included 116 APOB , 298 LDLR , and 5 PCSK9 . Sixty-six percent were female, the mean body mass index was 27.3, with 12.3% reporting a history of diabetes. Hypertriglyceridemia (≥150 mg/dL) was present in 39.5% and reduced HDL (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology & Hepatology, Department of Medicine (N.J.S.), Mayo Clinic, Phoenix, AZ. Genetic Counseling program, Arizona State University, Tucson.
- Center for Individualized Medicine (N.J.S., F.S., M.L.B., L.A.B., S.M.A., M.J.F., R.O., J.T.-A., J.A.M.-R., E.W.K., N.B.L., T.M.K., J.B.E., J.L.K., J.S.B., J.L.A., T.M.M.A., R.J.P., K.N.L.), Mayo Clinic, Rochester, MN.
- Comprehensive Cancer Center (N.J.S., J.M.S.-B., K.N.L.), Mayo Clinic, Rochester, MN.
- Mayo Clinic Alix School of Medicine (M.S., K.N.L.), Mayo Clinic, Phoenix, AZ. Genetic Counseling program, Arizona State University, Tucson.
- Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ (M.M.V., K.L.K., M.A.G.).
- Department of Clinical Genomics and Department of Cardiovascular Medicine (F.S.), Mayo Clinic, Phoenix, AZ. Genetic Counseling program, Arizona State University, Tucson.
ORCID-Profile: N Jewel Samadder, Mariah Schroeder, Molly M Voss, Fadi Shamoun, Iftikhar Kullo, Timothy B Curry, Elisa J F Houwink, Michelle L Bublitz, Lorelei A Bandel, Sebastian M Armasu, Robert A Vierkant, Matthew J Ferber, Rory Olson, Jennifer Tan-Arroyo, Joel A Morales-Rosado, Eric W Klee, Nicholas B Larson, Teresa M Kruisselbrink, Jan B Egan, Jessa S Bidwell, Linnea M Baudhuin, Katie L Kunze, Michael A Golafshar, Richard J Presutti, Konstantinos N Lazaridis
Zitieren
APA
Samadder, N. J., Schroeder, M., Voss, M. M., Shamoun, F., Kullo, I., Curry, T. B., Houwink, E. J. F., Bublitz, M. L., Bandel, L. A., Armasu, S. M., Vierkant, R. A., Ferber, M. J., Olson, R., Tan-Arroyo, J., Morales-Rosado, J. A., Klee, E. W., Larson, N. B., Kruisselbrink, T. M., Egan, J. B., …, & Lazaridis, K. N. (2025). Exome Sequencing Enhances Screening for Familial Hypercholesterolemia Within a Multi-Site Healthcare System. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.125.005174
Vancouver
Samadder NJ, Schroeder M, Voss MM, Shamoun F, Kullo I, Curry TB, et al. Exome Sequencing Enhances Screening for Familial Hypercholesterolemia Within a Multi-Site Healthcare System. Circulation: Genomic and Precision Medicine. 2025. doi:10.1161/circgen.125.005174
BibTeX
@article{Samadder2025,
author = {Samadder, N Jewel and Schroeder, Mariah and Voss, Molly M and Shamoun, Fadi and Kullo, Iftikhar and Curry, Timothy B and Houwink, Elisa J F and Bublitz, Michelle L and Bandel, Lorelei A and Armasu, Sebastian M and Vierkant, Robert A and Ferber, Matthew J and Olson, Rory and Tan-Arroyo, Jennifer and Morales-Rosado, Joel A and Klee, Eric W and Larson, Nicholas B and Kruisselbrink, Teresa M and Egan, Jan B and Kemppainen, Jennifer L and Bidwell, Jessa S and Anderson, Jennifer L and McAllister, Tammy M and Baudhuin, Linnea M and Kunze, Katie L and Golafshar, Michael A and Presutti, Richard J and Summer-Bolster, Jolene M and Lazaridis, Konstantinos N},
title = {Exome Sequencing Enhances Screening for Familial Hypercholesterolemia Within a Multi-Site Healthcare System},
journal = {Circulation: Genomic and Precision Medicine},
year = {2025},
doi = {10.1161/circgen.125.005174}
}
EUVIMED